Get 20% lifetime commission for referring investors to digrin.com
here.
Actinium Pharmaceuticals, Inc. (ATNM) Financials
ATNM Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 40.2 million | 9.9 million |
| March 31, 2026 | 45.4 million | 43.1 million |
| Dec. 31, 2025 | 51.8 million | 43.9 million |
| Sept. 30, 2025 | 56.2 million | 42.4 million |
ATNM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -5.7 million | 129000 |
| March 31, 2026 | -5.9 million | 11000 |
| Dec. 31, 2025 | -5.4 million | 10000 |
| Sept. 30, 2025 | -6.3 million | 109000 |
ATNM Net Income
No data available :(
ATNM Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 36.5 million | 595000 | - |
| March 31, 2026 | 42.1 million | - | 785000 |
| Dec. 31, 2025 | 48.0 million | - | 972000 |
| Sept. 30, 2025 | 53.4 million | - | 1.1 million |
ATNM Shares Outstanding
ATNM Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 478000 | 5.4 million | 2.1 million | - |
| March 31, 2026 | 2000 | 4.2 million | 1.7 million | - |
| Dec. 31, 2025 | 104000 | 4.9 million | 2.1 million | - |
| Sept. 30, 2025 | - | 4.2 million | 1.5 million | - |
ATNM Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 35.0 million | - |
| March 31, 2026 | - | 220000 |
| Dec. 31, 2025 | - | -615000 |
| Sept. 30, 2025 | 90000 | 206000 |
ATNM Revenue by Segment
Graph available only for paid members. Upgrade to see it.
ATNM
Price: $1.13
52 week price:
Earnings Per Share: -0.76 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 219900
Market Capitalization: 37.6 million